These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glucose- and Non-Glucose-Induced Mitochondrial Dysfunction in Diabetic Kidney Disease. Ito M; Gurumani MZ; Merscher S; Fornoni A Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327540 [TBL] [Abstract][Full Text] [Related]
4. Broadening horizons: the contribution of mitochondria-associated endoplasmic reticulum membrane (MAM) dysfunction in diabetic kidney disease. Liu Y; Qiao Y; Pan S; Chen J; Mao Z; Ren K; Yang Y; Feng Q; Liu D; Liu Z Int J Biol Sci; 2023; 19(14):4427-4441. PubMed ID: 37781026 [TBL] [Abstract][Full Text] [Related]
5. Mitochondria in Diabetic Kidney Disease. Ahmad AA; Draves SO; Rosca M Cells; 2021 Oct; 10(11):. PubMed ID: 34831168 [TBL] [Abstract][Full Text] [Related]
6. The role of endoplasmic reticulum-mitochondria-associated membranes in diabetic kidney disease. Elwakiel A; Mathew A; Isermann B Cardiovasc Res; 2024 Feb; 119(18):2875-2883. PubMed ID: 38367274 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of progression of diabetic kidney disease mediated by podocyte mitochondrial injury. Su J; Ye D; Gao C; Huang Q; Gui D Mol Biol Rep; 2020 Oct; 47(10):8023-8035. PubMed ID: 32918716 [TBL] [Abstract][Full Text] [Related]
9. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective. Zheng W; Guo J; Liu ZS Clin Epigenetics; 2021 Apr; 13(1):87. PubMed ID: 33883002 [TBL] [Abstract][Full Text] [Related]
10. Markers of Inflammation and Oxidative Stress in the Development and Progression of Renal Disease in Diabetic Patients. Hojs R; Ekart R; Bevc S; Hojs N Nephron; 2016; 133(3):159-62. PubMed ID: 27344598 [TBL] [Abstract][Full Text] [Related]
11. The Mitochondria-Targeted Metabolic Tubular Injury in Diabetic Kidney Disease. Jiang H; Shao X; Jia S; Qu L; Weng C; Shen X; Wang Y; Huang H; Wang Y; Wang C; Feng S; Wang M; Feng H; Geekiyanage S; Davidson AJ; Chen J Cell Physiol Biochem; 2019; 52(2):156-171. PubMed ID: 30816665 [TBL] [Abstract][Full Text] [Related]
12. Crosstalk Between Lipids and Mitochondria in Diabetic Kidney Disease. Ducasa GM; Mitrofanova A; Fornoni A Curr Diab Rep; 2019 Nov; 19(12):144. PubMed ID: 31754839 [TBL] [Abstract][Full Text] [Related]
13. New insights into the role of immunity and inflammation in diabetic kidney disease in the omics era. Hu X; Chen S; Ye S; Chen W; Zhou Y Front Immunol; 2024; 15():1342837. PubMed ID: 38487541 [TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of diabetic kidney disease and autophagy: A review. Yu J; Liu Y; Li H; Zhang P Medicine (Baltimore); 2023 Jul; 102(30):e33965. PubMed ID: 37505163 [TBL] [Abstract][Full Text] [Related]
18. Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets. Pichler R; Afkarian M; Dieter BP; Tuttle KR Am J Physiol Renal Physiol; 2017 Apr; 312(4):F716-F731. PubMed ID: 27558558 [TBL] [Abstract][Full Text] [Related]
19. Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility. Qi H; Casalena G; Shi S; Yu L; Ebefors K; Sun Y; Zhang W; D'Agati V; Schlondorff D; Haraldsson B; Böttinger E; Daehn I Diabetes; 2017 Mar; 66(3):763-778. PubMed ID: 27899487 [TBL] [Abstract][Full Text] [Related]
20. Mitochondrial dysfunction in diabetic tubulopathy. Yao L; Liang X; Qiao Y; Chen B; Wang P; Liu Z Metabolism; 2022 Jun; 131():155195. PubMed ID: 35358497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]